Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pharmala Biotech Holdings Inc MDXXF


Primary Symbol: C.MDMA

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:MDMA)

PharmAla Closes Private Placement and Concurrent Debt Settlement

GlobeNewswire 11 days ago

PharmAla Announces Private Placement and Concurrent Debt Settlement

GlobeNewswire April 10, 2024

Cortexa Commences Manufacturing GMP LaNeo(TM) MDMA in Australia

GlobeNewswire April 5, 2024

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

GlobeNewswire March 27, 2024

PharmAla Biotech Signs Sale Agreement with Numinus

GlobeNewswire March 26, 2024

Canadian Investment Regulatory Organization Trade Resumption - MDMA

Canada NewsWire March 20, 2024

Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office

GlobeNewswire March 20, 2024

Canadian Investment Regulatory Organization Trading Halt - MDMA

Canada NewsWire March 20, 2024

Cortexa Leads the World in First Supply of Psilocybin Under the TGA's Authorized Prescriber Scheme

GlobeNewswire March 18, 2024
View More News ››

Opinion & Analysis (CSE:MDMA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MDMA)

Financials are out on Sedar

As expected, as the company is just beginning to ramp up sales.  The next quarter will be of more interest.  Expenses are still...
inviolablspirit - 12 hours ago

RE:CEO Nick new interview.

Another link...same msg. https://www.theglobeandmail.com/investing/markets/markets-news/TheNewswire.com/25689641/pharmala-biotech...
Firepoker - 6 days ago

CEO Nick new interview.

[paid promotional message] Steve Darling interviews Nick Kadysh...here is the link below. https://youtu.be/SQNzcBwkxMU?feature=shared
Firepoker - 6 days ago

Status update on Trip collaboration .

https://ceo.ca/@newsfile/red-light-holland-initiates-psilocybin-extraction-phase
Firepoker - 7 days ago

Well done Nick

now investors can finally get rid of the ceo.ca flee bags who wanted a PP now they can go bother some mining pump on cse/tsxv for...
Chefboy69 - 11 days ago

TD and CIBC

I see both institutions are still working the stock, as they are many other stocks.  TD is like a virus infecting nearly every stock...
inviolablspirit - 13 days ago
View more Bullboard ››

Fintech Select Ltd.

Fintech Select Ltd.

Fintech Select is a provider of pre-paid card programs, an online payment platform, and a POS cryptocurrency platform that ...
View More »